First Header Logo Second Header Logo

Connection

Christopher Ohl to Treatment Outcome

This is a "connection" page, showing publications Christopher Ohl has written about Treatment Outcome.
Connection Strength

0.129
  1. Luther VP, Bookstaver PB, Ohl CA. Corticosteroids in the treatment of hepatic tuberculosis: case report and review of the literature. Scand J Infect Dis. 2010 Apr; 42(4):315-7.
    View in: PubMed
    Score: 0.051
  2. Moyenuddin M, Williamson JC, Ohl CA. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy. Curr Gastroenterol Rep. 2002 Aug; 4(4):279-86.
    View in: PubMed
    Score: 0.030
  3. Wrenn RH, Cluck D, Kennedy L, Ohl C, Williamson JC. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. J Oncol Pharm Pract. 2018 Apr; 24(3):170-175.
    View in: PubMed
    Score: 0.020
  4. Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection. Clin Infect Dis. 2015 Sep 15; 61(6):934-41.
    View in: PubMed
    Score: 0.018
  5. Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006 Sep; 130(3):787-93.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.